BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37345035)

  • 1. Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
    Nickl V; Eck J; Goedert N; Hübner J; Nerreter T; Hagemann C; Ernestus RI; Schulz T; Nickl RC; Keßler AF; Löhr M; Rosenwald A; Breun M; Monoranu CM
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
    Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives.
    Chan WS; Mo X; Ip PPC; Tse KY
    Cancer Med; 2023 Oct; 12(19):19714-19731. PubMed ID: 37776168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
    Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
    Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors.
    Zhou S; Lu J; Liu S; Shao J; Liu Z; Li J; Xiao W
    Front Cell Dev Biol; 2023; 11():1166916. PubMed ID: 37152280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomanufacturing of glioblastoma organoids exhibiting hierarchical and spatially organized tumor microenvironment via transdifferentiation.
    Park S; Avera AD; Kim Y
    Biotechnol Bioeng; 2022 Nov; 119(11):3252-3274. PubMed ID: 35869574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine.
    Spagnol G; Sensi F; De Tommasi O; Marchetti M; Bonaldo G; Xhindoli L; Noventa M; Agostini M; Tozzi R; Saccardi C
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids.
    Chen H; Yang Y; Shi J; Yan T; Wang J; Yang Y; Lu Q; Feng H; Du J; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2024; 24(5):546-555. PubMed ID: 37997804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing.
    Bi J; Newtson AM; Zhang Y; Devor EJ; Samuelson MI; Thiel KW; Leslie KK
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Cancer Organoids for Precision Oncology Treatment.
    Pernik MN; Bird CE; Traylor JI; Shi DD; Richardson TE; McBrayer SK; Abdullah KG
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34067714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper.
    Alsalkini M; Cibulková V; Breun M; Kessler AF; Schulz T; Cattaneo A; Wipplinger C; Hübner J; Ernestus RI; Nerreter T; Monoranu CM; Hagemann C; Löhr M; Nickl V
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38314829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible.
    Girda E; Huang EC; Leiserowitz GS; Smith LH
    Int J Gynecol Cancer; 2017 Oct; 27(8):1701-1707. PubMed ID: 28683005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening.
    Luo Z; Wang B; Luo F; Guo Y; Jiang N; Wei J; Wang X; Tseng Y; Chen J; Zhao B; Liu J
    BMC Med; 2023 Sep; 21(1):336. PubMed ID: 37667332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro Models.
    Landon-Brace N; Li NT; McGuigan AP
    Adv Healthc Mater; 2023 Oct; 12(26):e2300903. PubMed ID: 37589373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond.
    Weitz JR; Tiriac H; Hurtado de Mendoza T; Wascher A; Lowy AM
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
    Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
    BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
    Erices JI; Bizama C; Niechi I; Uribe D; Rosales A; Fabres K; Navarro-Martínez G; Torres Á; San Martín R; Roa JC; Quezada-Monrás C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
    Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
    Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.